Abstract
IMPORTANCE It is unclear whether time-restricted eating (TRE) induces cardiometabolic benefits independently of the reduction in calorie intake and whether its effects depend on the timing of the eating window.
OBJECTIVE The main objective was to determine whether 8-hour TRE alters insulin sensitivity in an isocaloric setting. The secondary objective was to compare effects of early (eTRE) vs. late TRE (lTRE) on cardiometabolic outcomes and internal circadian time.
DESIGN, SETTING, AND PARTICIPANTS The study was a randomized 10-week crossover trial conducted at the German Institute of Human Nutrition Potsdam-Rehbruecke, Germany, between March 2020 to December 2021. Participants were non-diabetic women with overweight or obesity, aged 18 to 70 years.
INTERVENTIONS All participants underwent two 2-week isocaloric interventions with a restriction of the eating period to 8 hours: (i) early in the day (eTRE: 8:00-16:00 hr) and (ii) late in the day (lTRE: 13:00-21:00 hr).
MAIN OUTCOMES AND MEASURES The primary outcome was insulin sensitivity assessed by an oral glucose tolerance test. Secondary outcomes included levels of glucose, lipids, adipokines, cytokines, oxidative stress markers, and internal circadian phase.
RESULTS 31 female participants (mean (SD) BMI of 30.5 (2.9) and median [IQR] age of 62 [53-65] years) completed the trial. Timely adherence was 96.5 % in eTRE and 97.7 % in lTRE. Food records showed a minor daily calorie deficit in eTRE (-167 kcal) but not in lTRE. Insulin sensitivity did not differ between eTRE and lTRE (-0.07; 95% CI, -0.77 to 0.62, P = .83) and showed no within-intervention changes (eTRE: 0.31; 95% CI, -0.14 to 0.76, P = .11; lTRE: 0.19; 95% CI, -0.22 to 0.60, P = .25). 24-hour glucose levels, lipid, inflammatory, and oxidative stress markers showed no clinically meaningful between- and within-intervention differences. lTRE delayed the circadian phase in blood monocytes (24 min; 95% CI, -5 to 54 min, P = .10) and sleep midpoint (15 min; 95% CI, 7 to 22 min, P = .001) compared to eTRE.
CONCLUSIONS AND RELEVANCE In a nearly isocaloric setting, neither eTRE nor lTRE improve insulin sensitivity or other cardiometabolic traits despite significant changes in the circadian system.
TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT04351672
QUESTIONS Does isocaloric time-restricted eating (TRE) alter insulin sensitivity and cardiometabolic traits? Do effects differ for early and late TRE?
FINDINGS In this randomized crossover trial that included 31 women with overweight and obesity, isocaloric early and late TRE showed no clinically meaningful differences in insulin sensitivity, mean 24-hour glucose or other glycemic, lipid, inflammatory, and oxidative stress markers between and within-interventions. Late TRE delayed the circadian clock phase and sleep timing compared to early TRE.
MEANING In an isocaloric setting, neither early nor late TRE influence insulin sensitivity or cardiometabolic traits despite shifting internal circadian time.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT04351672
Funding Statement
This study was funded by grants from the German Science Foundation (DFG RA 3340/3-1, project number 434112826, and RA 3340/4-1, project number 530918029 to O.P.-R.), of the German Diabetic Association (Allgemeine Projektfoerderung of DDG, 2020 to O.P.-R.; Adam-Heller-Projektfoerderung of DDG/Abbott, 2021, to O.P.-R.); of the European Association of Study of Diabetes (EASD Morgagni Prize, 2020 to O.P.-R.).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of the University of Potsdam, Germany, gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
